Elipten
Brand names,
Elipten
Analogs
Elipten
Brand Names Mixture
Elipten
Chemical_Formula
C13H16N2O2
Elipten
RX_link
http://www.rxlist.com/cgi/generic3/cytadren.htm
Elipten
fda sheet
Elipten
msds (material safety sheet)
Elipten
Synthesis Reference
Hoffmann, Urech, U.S. pat. 2,848,455 (1958 to Ciba)
Elipten
Molecular Weight
232.278 g/mol
Elipten
Melting Point
149-150 oC
Elipten
H2O Solubility
Practically insoluble in water
Elipten
State
Solid
Elipten
LogP
2.029
Elipten
Dosage Forms
Tablet (250 mg)
Elipten
Indication
For the suppression of adrenal function in selected patients with Cushing's syndrome, malignant neoplasm of the female breast, and carcinoma in situ of the breast.
Elipten
Pharmacology
Aminoglutethimide inhibits the enzymatic conversion of cholesterol to D5-pregnenolone, resulting in a decrease in the production of adrenal glucocorticoids, mineralocorticoids, estrogens, and androgens.
Elipten
Absorption
Rapidly and completely absorbed from gastrointestinal tract. The bioavailability of tablets is equivalent to equal doses given as a solution.
Elipten
side effects and Toxicity
Oral LD50s (mg/kg): rats, 1800; dogs, >100. Intravenous LD50s (mg/kg): rats, 156; dogs, >100. Symptoms of overdose include respiratory depression, hypoventilation, hypotension, hypovolemic shock due to dehydration, somnolence, lethargy, coma, ataxia, dizziness, fatigue, nausea, and vomiting.
Elipten
Patient Information
Elipten
Organisms Affected
Humans and other mammals